Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · IEX Real-Time Price · USD
6.66
+0.14 (2.15%)
At close: May 1, 2024, 4:00 PM
7.02
+0.36 (5.38%)
After-hours: May 1, 2024, 6:48 PM EDT
Relay Therapeutics Revenue
In the year 2023, Relay Therapeutics had annual revenue of $25.55M with 1,749.82% growth. Revenue in the quarter ending December 31, 2023 was $-1.00K, a -100.40% decrease year-over-year.
Revenue (ttm)
$25.55M
Revenue Growth
+1,749.82%
P/S Ratio
34.20
Revenue / Employee
$79,090
Employees
323
Market Cap
873.65M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 25.55M | 24.17M | 1,749.82% |
Dec 31, 2022 | 1.38M | -1.65M | -54.41% |
Dec 31, 2021 | 3.03M | -79.63M | -96.34% |
Dec 31, 2020 | 82.65M | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OPKO Health | 863.50M |
Avanos Medical | 673.30M |
Artivion | 354.00M |
BioCryst Pharmaceuticals | 331.41M |
EyePoint Pharmaceuticals | 46.02M |
Mesoblast | 7.25M |
Viridian Therapeutics | 314.00K |
ARS Pharmaceuticals | 30.00K |
RLAY News
- 6 days ago - Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024 - GlobeNewsWire
- 20 days ago - Relay Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Relay Therapeutics to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights - GlobeNewsWire
- 2 months ago - Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024 - GlobeNewsWire
- 3 months ago - Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewsWire
- 4 months ago - Relay Therapeutics Announces $30 Million Private Placement Financing - GlobeNewsWire
- 4 months ago - Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire